CSF2 and tuberculosis: In human monocyte-derived macrophage cell lines, recombinant human granulocyte-macrophage colony-stimulating factor, which has cytokine regulatory abilities, was observed to reduce Mycobacterium growth, indicating its potential use as adjunct TB treatment [29].